Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
26.03
-0.50 (-1.88%)
At close: Feb 12, 2026

SHE:003020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
402.57439.69502.93642.58654.25766.59
Short-Term Investments
80.610.67----
Trading Asset Securities
0.115861.520.120.13-
Cash & Short-Term Investments
483.28508.36564.45642.7654.39766.59
Cash Growth
-0.90%-9.94%-12.17%-1.79%-14.64%243.39%
Accounts Receivable
390.97415.63295.19321.02318.37285.28
Other Receivables
9.098.0819.9736.036.083.07
Receivables
400.06423.7315.16357.05324.45288.36
Inventory
270.07220.48242.91361.76188.86193.8
Prepaid Expenses
-1.411.11---
Other Current Assets
35.7531.5427.5191.0351.9543.22
Total Current Assets
1,1891,1851,1511,4531,2201,292
Property, Plant & Equipment
988.2972.75898.62538.12299.03199.03
Long-Term Investments
193.09194.11180.3914.420.71-
Goodwill
74.4474.4474.44---
Other Intangible Assets
101.15105.24113.2983.3889.5131.42
Long-Term Deferred Tax Assets
15.4314.5116.138.585.863.37
Long-Term Deferred Charges
4.046.947.417.618.80.9
Other Long-Term Assets
32.1932.4942.2616.7630.99.33
Total Assets
2,5982,5862,4842,1211,6741,536
Accounts Payable
373.68347.53301.25460.66242.93280.28
Accrued Expenses
24.4963.1953.9545.2550.527.82
Short-Term Debt
-5050.05---
Current Portion of Leases
6.244.364.5410.03--
Current Income Taxes Payable
29.419.0815.5312.716.051.92
Current Unearned Revenue
13.0333.0833.0942.6214.6920.01
Other Current Liabilities
91.374.7184.3251.3613.8812.32
Total Current Liabilities
538.14581.95542.73622.63328.05342.35
Long-Term Debt
59.6459.6531.01---
Long-Term Leases
0.344.572.843.3824.58-
Long-Term Unearned Revenue
46.3918.2820.1612.9813.2415.02
Long-Term Deferred Tax Liabilities
7.738.9313.431.39--
Other Long-Term Liabilities
---1.164.664.66
Total Liabilities
652.24673.38610.18641.53370.53362.03
Common Stock
190.18191.57159.68122.4792.6492.64
Additional Paid-In Capital
505.93518551.89554.93526.16522.15
Retained Earnings
1,1031,038994.95829.51685.11559.2
Treasury Stock
--9.39-20.99-27.05--
Total Common Equity
1,7991,7381,6861,4801,3041,174
Minority Interest
146.5174.71187.97---
Shareholders' Equity
1,9451,9131,8731,4801,3041,174
Total Liabilities & Equity
2,5982,5862,4842,1211,6741,536
Total Debt
66.22118.5888.4413.4124.58-
Net Cash (Debt)
417.06389.78476629.28629.8766.59
Net Cash Growth
-0.39%-18.11%-24.36%-0.08%-17.84%284.83%
Net Cash Per Share
2.182.042.483.333.355.43
Filing Date Shares Outstanding
190.18191.26191.61191.05187.87187.87
Total Common Shares Outstanding
190.18191.57191.61191.05187.87187.87
Working Capital
651.01603.54608.42829.92891.59949.61
Book Value Per Share
9.469.078.807.756.946.25
Tangible Book Value
1,6231,5581,4981,3961,2141,143
Tangible Book Value Per Share
8.548.137.827.316.466.08
Buildings
-547.66395.67140.12127.89125.55
Machinery
-480.99303.79174.84139.8105.97
Construction In Progress
-269.34459.66340.89130.3566.47
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.